Lipoxygenase inhibiting compounds
US4897422A · kind A · utility
9Cited by
5References
6Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Feb 10, 1987 |
| Grant date | Jan 30, 1990 |
| Priority date | — |
| Expiry date | Feb 10, 2007 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of the formula: ##STR1## where R.sub.1 is amino or methyl; R.sub.2 is C.sub.1 -C.sub.2 alkyl; R.sub.3 is one or more substituents selected from hydrogen, halogen or trihalomethyl; R.sub.4 is one or more substituents selected from hydrogen, halogen, trihalomethyl, C.sub.1 to C.sub.4 alkoxy or C.sub.1 to C.sub.4 alkyl; and M is hydrogen, a pharmaceutically acceptable cation, aroyl, or C.sub.1 to C.sub.6 alkoyl are inhibitors of 5- and/or 12-lipoxygenase enzymes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.